JPH04235112A - Tyrosinase-inhibitor - Google Patents
Tyrosinase-inhibitorInfo
- Publication number
- JPH04235112A JPH04235112A JP3002020A JP202091A JPH04235112A JP H04235112 A JPH04235112 A JP H04235112A JP 3002020 A JP3002020 A JP 3002020A JP 202091 A JP202091 A JP 202091A JP H04235112 A JPH04235112 A JP H04235112A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- tyrosinase
- compound
- inhibitor
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101710147108 Tyrosinase inhibitor Proteins 0.000 title claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 21
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims abstract description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 abstract description 10
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 abstract description 10
- 239000000243 solution Substances 0.000 abstract description 10
- 239000003795 chemical substances by application Substances 0.000 abstract description 9
- 230000002401 inhibitory effect Effects 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 8
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 abstract description 8
- WXTPOHDTGNYFSB-RMPHRYRLSA-N (2s,3r,4s,5s,6r)-2-(3,5-dihydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1 WXTPOHDTGNYFSB-RMPHRYRLSA-N 0.000 abstract description 6
- WXTPOHDTGNYFSB-UHFFFAOYSA-N Phlorin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1 WXTPOHDTGNYFSB-UHFFFAOYSA-N 0.000 abstract description 6
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical class OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 abstract description 6
- 229960000271 arbutin Drugs 0.000 abstract description 5
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 abstract description 5
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 abstract description 5
- 235000019139 phlorizin Nutrition 0.000 abstract description 5
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 abstract description 4
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 abstract description 4
- 239000007864 aqueous solution Substances 0.000 abstract description 4
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 abstract description 4
- 229960004705 kojic acid Drugs 0.000 abstract description 4
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003960 organic solvent Substances 0.000 abstract description 2
- IOUVKUPGCMBWBT-DARKYYSBSA-N Phloridzin Natural products O[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-DARKYYSBSA-N 0.000 abstract 1
- IOUVKUPGCMBWBT-QNDFHXLGSA-N phlorizin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-QNDFHXLGSA-N 0.000 abstract 1
- 102000003425 Tyrosinase Human genes 0.000 description 15
- 108060008724 Tyrosinase Proteins 0.000 description 15
- 239000000203 mixture Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000002087 whitening effect Effects 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 150000008495 β-glucosides Chemical class 0.000 description 6
- 239000006071 cream Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 229940126902 Phlorizin Drugs 0.000 description 4
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 4
- IOUVKUPGCMBWBT-GHRYLNIYSA-N phlorizin Chemical compound O[C@@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-GHRYLNIYSA-N 0.000 description 4
- 229960001553 phloroglucinol Drugs 0.000 description 4
- 235000014102 seafood Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 241000220225 Malus Species 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- -1 polyoxyethylene Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- CAYPFLMKYYVWAT-UHFFFAOYSA-N dodecanoic acid;ethanol Chemical compound CCO.CCCCCCCCCCCC(O)=O CAYPFLMKYYVWAT-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Storage Of Fruits Or Vegetables (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
【0001】0001
【発明の分野】本発明は、チロシナーゼ阻害剤に関する
。より詳細には、本発明は、1,3,5−トリヒドロキ
シベンゼン誘導体を活性成分とし、皮膚美白剤、食品等
の黒変・褐変防止剤等として使用可能なチロシナーゼ阻
害剤に関する。FIELD OF THE INVENTION This invention relates to tyrosinase inhibitors. More specifically, the present invention relates to a tyrosinase inhibitor that contains a 1,3,5-trihydroxybenzene derivative as an active ingredient and can be used as a skin whitening agent, a blackening/browning inhibitor for foods, etc.
【0002】0002
【発明の解決しようとする問題点】人間の皮膚に発生す
るシミ、ソバカス等は主として日焼け等によって起る組
織中のメラニンの形成に原因を有する。また魚介類、青
果物等の生鮮食料品の黒変・褐変もメラニンの形成を原
因とするものである。Problems to be Solved by the Invention The stains, freckles, etc. that occur on human skin are mainly caused by the formation of melanin in tissues caused by sunburn, etc. The formation of melanin is also responsible for the blackening and browning of fresh foods such as seafood and fruits and vegetables.
【0003】メラニンは、最初にチロシンがチロシナー
ゼにより酵素的に酸化され、その後数段階の反応を経て
形成されることが知られている。[0003] Melanin is known to be formed by first enzymatically oxidizing tyrosine by tyrosinase, and then through several reaction steps.
【0004】従って、チロシナーゼの活性を有効に阻害
する物質は、皮膚美白化粧料、食品の黒変防止剤等に使
用するのに極めて有用である。[0004] Therefore, substances that effectively inhibit tyrosinase activity are extremely useful for use in skin whitening cosmetics, anti-blackening agents for foods, and the like.
【0005】[0005]
【問題を解決するための手段】本発明者等は、上記背景
に鑑み、チロシナーゼ活性阻害物質を探求したところ、
下記一般式I:[Means for solving the problem] In view of the above background, the present inventors have searched for tyrosinase activity inhibitors and found that
General formula I below:
【0006】[0006]
【化6】[C6]
【0007】[式中、R1 は個々に水素原子またはグ
ルコース残基を表し、R2 は水素原子又は基[In the formula, R1 each represents a hydrogen atom or a glucose residue, and R2 represents a hydrogen atom or a group]
【000
8】000
8]
【化7】[C7]
【0009】を表し、但しR1 の少なくとも1つは必
ず水素原子を表すが、R1 のすべてとR2 が同時に
水素を表すことはない]を有する化合物が顕著なチロシ
ナーゼ阻害活性を有することを見出し、本発明を完成す
るに至った。[0009] However, at least one of R1 always represents a hydrogen atom, but all R1 and R2 do not represent hydrogen at the same time] We have discovered that a compound has remarkable tyrosinase inhibitory activity, and we have developed this invention. The invention was completed.
【0010】従って本発明は、下記一般式ITherefore, the present invention provides the following general formula I
【0011
】0011
]
【化8】[Chemical formula 8]
【0012】[式中、R1 は個々に水素原子またはグ
ルコース残基を表し、R2 は水素原子又は基[In the formula, R1 each represents a hydrogen atom or a glucose residue, and R2 represents a hydrogen atom or a group]
【001
3】001
3]
【化9】[Chemical formula 9]
【0014】を表し、但しR1 の少なくとも1つは必
ず水素原子を表すが、R1 のすべてとR2 が同時に
水素を表すことはない]を有する化合物を活性成分とす
るチロシナーゼ阻害剤である。[0014] A tyrosinase inhibitor containing a compound having the following formula as an active ingredient, provided that at least one of R1 always represents a hydrogen atom, but all of R1 and R2 do not represent hydrogen at the same time.
【0015】上記一般式を有する化合物の例としては、
下記のような化合物が挙げられる。Examples of compounds having the above general formula are:
Examples include the following compounds.
【0016】[0016]
【化10】[Chemical formula 10]
【0017】上記例示した化合物はいずれも公知の化合
物であるが、チロシナーゼ阻害活性を有することは知ら
れていなかったものである。The compounds exemplified above are all known compounds, but they were not known to have tyrosinase inhibitory activity.
【0018】[0018]
【実施例】上記一般式Iの種々の化合物、即ち、フロリ
ン、フロリジン及びフロレチンを使用して各化合物のチ
ロシナーゼ阻害活性を測定した。フロリジン及びフロレ
チンは和光ケミカル社より試薬として販売されているも
のを使用し、フロリンは下記のようにしてフロリジンか
ら製造した。EXAMPLES The tyrosinase inhibitory activity of each compound was measured using various compounds of the above general formula I, ie, phlorin, phlorizin, and phloretin. Phlorizin and phloretin were sold as reagents by Wako Chemical Co., Ltd., and phlorin was produced from phlorizin in the following manner.
【0019】フロリンの調製
フロリジン1gを10%の水酸化バリウム水溶液 10
0ml中で30分間約 100℃に加熱し、加水分解し
てフロリンを生成させた。この条件下では、配糖体結合
は加水分解されない。Preparation of Phlorin 1 g of Phlorin was mixed with 10% barium hydroxide aqueous solution 10
It was heated to about 100° C. for 30 minutes in 0 ml and hydrolyzed to produce florin. Under this condition, glycoside bonds are not hydrolyzed.
【0020】希H2 HO4 で反応液を中和後、その
濾液を乾固し、次にシリカゲル(ワコー200メッシュ
)のカラムクロマトグラフィー(ベンゼン:エタノール
=9:1)にて精製して得られたフロリンは純白色結晶
で、融点 231〜233 °、比旋光度[α]D 2
2−74.58°であった。After neutralizing the reaction solution with dilute H2 HO4, the filtrate was dried and then purified by column chromatography on silica gel (Wako 200 mesh) (benzene:ethanol = 9:1). Florin is a pure white crystal with a melting point of 231-233° and a specific optical rotation [α]D 2
It was 2-74.58°.
【0021】チロシナーゼ阻害試験
各化合物の0.05%水溶液を試料とし、下記の試験手
順により行った。Tyrosinase inhibition test A 0.05% aqueous solution of each compound was used as a sample, and the following test procedure was conducted.
【0022】チロシン(0.3mg/ml)を20mg
、マッキルベイン緩衝液(pH6.8)を20ml、寒
天を0.6g三角フラスコに入れ、撹拌後、加熱沸騰さ
せてから冷却して45℃になったとき、チロシナーゼ溶
液(1mg/ml)を0.2ml加え、撹拌後シャーレ
に移して寒天平板をつくり、試料を含浸させた直径10
mmのペーパーディスクを置いて、それを中心とした阻
止円径の大小を測定し、チロシナーゼ阻害効果を判定し
た。同時に、チロシナーゼ阻害効果の大きいことが知ら
れているコウジ酸、アルブチンについても対照として測
定した。結果を次の表1に示す。20mg of tyrosine (0.3mg/ml)
, 20 ml of McIlvaine buffer (pH 6.8) and 0.6 g of agar were placed in an Erlenmeyer flask, stirred, heated to boiling, and then cooled to 45°C. When the temperature reached 45°C, tyrosinase solution (1 mg/ml) was added to Add 2 ml, stir, and transfer to a Petri dish to make an agar plate.
A paper disk (mm) was placed, and the diameter of the inhibition circle centered on the disk was measured to determine the tyrosinase inhibitory effect. At the same time, kojic acid and arbutin, which are known to have a large tyrosinase inhibitory effect, were also measured as controls. The results are shown in Table 1 below.
【0023】[0023]
【表1】[Table 1]
【0024】*24時間経過後、水、アルブチン、コウ
ジ酸のペーパーディスクは黒褐色に変色していたが、フ
ロリン、フロリジン、フロレチンのペーバーディスクは
白色のままであった。*After 24 hours, the water, arbutin, and kojic acid paper discs had turned blackish brown, but the florin, phlorizin, and phloretin paper discs remained white.
【0025】また上記と同じ試料を使用し、チロシン溶
液(30mg/200ml)10ml、マッキルベイン
緩衝液(pH6.8)10ml、蒸留水20mlに、試
料を1ml加え、37℃で10分間インキュベートした
後、チロシナーゼ溶液(15mg/15ml、シグマ社
)を0.1ml投入し、スターラで撹拌しながら、65
0nmで30分毎に吸光度を測定し、メラニンの生成を
測定した。アスコルビン酸とアルブチンを対照とした。
結果を下記表2に示す。[0025] Using the same sample as above, 1 ml of the sample was added to 10 ml of tyrosine solution (30 mg/200 ml), 10 ml of McIlvaine buffer (pH 6.8), and 20 ml of distilled water, and after incubation at 37°C for 10 minutes, Add 0.1 ml of tyrosinase solution (15 mg/15 ml, Sigma), stir with a stirrer,
Absorbance was measured every 30 minutes at 0 nm to measure melanin production. Ascorbic acid and arbutin were used as controls. The results are shown in Table 2 below.
【0026】[0026]
【表2】[Table 2]
【0027】各試料について得られた吸光度を時間に対
してプロットしたグラフを第1図に示す。A graph in which the absorbance obtained for each sample is plotted against time is shown in FIG.
【0028】上記結果から判るように、本発明の式Iの
化合物は、これまでチロシナーゼ阻害活性を有すること
が知られているコウジ酸、アルブチン等と比較して同等
以上のチロシナーゼ阻害活性を有するものであり、美白
化粧料、食品の黒変防止剤等に使用するのに極めて有用
である。As can be seen from the above results, the compound of formula I of the present invention has a tyrosinase inhibitory activity equivalent to or higher than that of kojic acid, arbutin, etc., which have been known to have tyrosinase inhibitory activity. Therefore, it is extremely useful for use in whitening cosmetics, anti-blackening agents for foods, etc.
【0029】本発明のチロシナーゼ阻害剤を含む美白化
粧料は、従来使用されている化粧料基材を用いて常法に
より、クリーム、乳液、化粧水等の適当な形態で製造す
ることができる。また、該美白化粧料は、紫外線吸収剤
、紫外線散乱剤、その他の薬効成分、増粘剤、可塑剤、
着色料、香料等の任意の公知の添加物を含有することが
できる。The whitening cosmetic containing the tyrosinase inhibitor of the present invention can be produced in an appropriate form such as a cream, milky lotion, lotion, etc. by a conventional method using conventionally used cosmetic base materials. In addition, the whitening cosmetics include ultraviolet absorbers, ultraviolet scattering agents, other medicinal ingredients, thickeners, plasticizers,
Any known additives such as colorants and fragrances can be contained.
【0030】本発明のチロシナーゼ阻害剤を美白化粧料
に使用する場合、化粧料100g当り上記一般式Iの化
合物を0.5〜1g程度含むような量で使用するのが好
ましい。When the tyrosinase inhibitor of the present invention is used in whitening cosmetics, it is preferably used in an amount such that about 0.5 to 1 g of the compound of general formula I is contained per 100 g of the cosmetic.
【0031】また、本発明のチロシナーゼ阻害剤を食品
の黒変防止剤に使用する場合には、上記一般式Iの化合
物の水溶液または適当な有機溶媒中の溶液として使用す
るのが好ましく、さらに任意の添加剤を含んでいてもよ
い。食品の黒変防止剤に使用する場合には、溶液100
l 当り上記一般式一の化合物を1〜2g含むような量
で使用することが好ましい。When the tyrosinase inhibitor of the present invention is used as a blackening inhibitor for foods, it is preferably used as an aqueous solution of the compound of the above general formula I or as a solution in a suitable organic solvent. It may contain additives. When used as an anti-blackening agent for foods, solution 100
It is preferable to use an amount such that 1 to 2 g of the compound of the above general formula 1 is contained per 1 liter of the compound.
【0032】の混合溶液を撹拌しながら加えて均一な溶
液とし、皮膚美白効果を有する化粧水を得る。A mixed solution of [0032] is added while stirring to obtain a homogeneous solution, thereby obtaining a lotion having a skin whitening effect.
【0033】[0033]
【実施例】実施例1
化粧水(油性)
ソルビトール(70%)
3.0gグリセリン
5.0gフロリ
ン(フロログルシノール− 0.
2gβ−グルコサイド)
水
70.0gこれらの成分を混
合溶解する。これに、アラントイン
0.1gポリオ
キシエチレン硬化ヒマシ油誘導体 0.5gエタノ
ール
20.0g香 料
適 量
の混合溶液を撹拌しながら加えて均一な溶液とし、皮膚
美白効果を有する化粧水を得る。[Example] Example 1 Lotion (oil-based) Sorbitol (70%)
3.0g glycerin
5.0g Phlorin (phloroglucinol-0.
2g β-glucoside) water
Mix and dissolve 70.0g of these ingredients. In this, allantoin
0.1g polyoxyethylene hydrogenated castor oil derivative 0.5g ethanol
20.0g fragrance
Add an appropriate amount of the mixed solution while stirring to obtain a homogeneous solution to obtain a lotion having a skin whitening effect.
【0034】実施例2
化粧水(乾性)
エチレングリコール
2.5gプロピレングリコール
5.0gシリコーン
0.
0001gフロリン(フロログルシノール−
0.1gβ−グルコサイド)
水
70.0gこれらの成分を混
合溶解する。これに、尿 素
1.0
gポリオキシエチレンソルビタン
1.2gモノラウレート
エタノール
20gε−アミノカプロン酸
0.1g香 料
適 量実施例3
洗顔クリーム
グリセリン
2.0gステアリン酸
20.0g
ミリスチン酸
10.0gラウリン酸
5.0g
ポリオキシエチレンラウリルエーテル 1.0
gフロリン(フロログルシノール−
0.5gβ−グルコサイド)
香料および防腐剤
適 量これらの成分を混合し、約75℃で
加熱溶解し、これに、約75℃に加熱した、
水酸化カリウム
5.5g水
56
.0gの溶液を撹拌しながら加えた後、冷却して皮膚美
白効果を有する洗顔クリームを得る。Example 2 Lotion (drying) Ethylene glycol
2.5g propylene glycol
5.0g silicone
0.
0001g phlolin (phloroglucinol)
0.1g β-glucoside) water
Mix and dissolve 70.0g of these ingredients. In addition, urea
1.0
g Polyoxyethylene sorbitan
1.2g monolaurate ethanol
20gε-aminocaproic acid
0.1g fragrance
Appropriate amount Example 3 Facial cleansing cream glycerin
2.0g stearic acid
20.0g
myristic acid
10.0g lauric acid
5.0g
Polyoxyethylene lauryl ether 1.0
g florin (phloroglucinol)
0.5g β-glucoside) Flavoring and preservatives
Mix appropriate amounts of these ingredients, heat and dissolve at about 75°C, and add potassium hydroxide heated to about 75°C.
5.5g water
56
.. After adding 0 g of the solution with stirring, it is cooled to obtain a facial cleansing cream with skin whitening effect.
【0035】実施例4
パック
ポリビニルアルコール
15.0g防 腐 剤
0.1g水
75.0gフロリン(フロログル
シノール− 0.3gβ−グルコサイ
ド)
これらの成分を混合し、約80℃で加熱溶解後、室温ま
で冷却し、
グリセリン
4.0gエタノール
5.0
g香 料
適 量を混合して均一に溶
解し、パックを得る。Example 4 Packed polyvinyl alcohol
15.0g preservative
0.1g water
75.0g phlolin (phloroglucinol - 0.3g β-glucoside) Mix these ingredients, heat and dissolve at about 80°C, cool to room temperature, and prepare glycerin.
4.0g ethanol
5.0
g fragrance
Mix appropriate amounts and dissolve uniformly to obtain a pack.
【0036】実施例5
油性クリーム
ミツロウ
10.0gパラフィンワックス
6.0gラノ
リン
3.0gイソプロピルミリステート
6.0gスクワラン
8.0g流動パラフィン
25.0gフロリン(フロロ
グルシノール− 0.5gβ−グルコ
サイド)
ポリオキシエチレンソルビタン
1.8gモノステアレート
ソルビタンモノステアレート
4.2g防 腐 剤
適 量これらの成分
を混合し、約75℃で加熱溶解し、これに約75℃に加
熱した、
プロピレングリコール
2.0gホ ウ 砂
0.7g尿
素
5.0g水
28.0gの混合物を攪拌しながら加え、冷却した後
、55℃で香料を適量加え、攪拌しながら45℃まで冷
却し、放置して油性クリームを得る。Example 5 Oil-based cream beeswax
10.0g paraffin wax
6.0g lanolin
3.0g isopropyl myristate
6.0g squalane
8.0g liquid paraffin
25.0g Florin (phloroglucinol - 0.5g β-glucoside) Polyoxyethylene sorbitan
1.8g Monostearate Sorbitan Monostearate
4.2g preservative
Mix appropriate amounts of these ingredients, heat and melt at about 75°C, and add propylene glycol heated to about 75°C.
2.0g Borax Sand
0.7g urine
Basic
5.0g water
Add 28.0 g of the mixture with stirring, and after cooling, add an appropriate amount of fragrance at 55°C, cool to 45°C while stirring, and leave to obtain an oily cream.
【0037】実施例6
青果物褐黒変防止剤
水 500mlにフロリン(フロログルシノール−β−
グルコサイド) 0.5gを溶解し、これに皮をむいた
リンゴを2分間接触させた。対照区(接触させないもの
)は5分後には変色したが本発明のチロシナーゼ阻害剤
からなる青果物の褐黒変防止剤に接触させたリンゴは1
5分後も変色は認められなかった。Example 6 Florin (phloroglucinol-β-
Glucoside) 0.5g was dissolved and a peeled apple was brought into contact with the solution for 2 minutes. The control group (no contact) changed color after 5 minutes, but the apples that were brought into contact with the agent for preventing browning of fruits and vegetables consisting of the tyrosinase inhibitor of the present invention changed color after 5 minutes.
No discoloration was observed even after 5 minutes.
【0038】実施例7
魚介類黒褐変防止剤
L−アスコルビン酸
3.0g乳 糖
65.0g
フロリン(フロログルシノール− 0
.5gβ−グルコサイド)
ソルビトール
6.0gL−アスコルビン酸ナトリウ
ム 20.0gミョウバン
5.5gの混合物を 500〜1000mlの水または
海水に溶かし、魚介類を5〜10分間浸漬させることに
より魚介類の黒褐変を抑制させる。Example 7 Seafood browning inhibitor L-ascorbic acid
3.0g lactose
65.0g
Phlolin (phloroglucinol-0)
.. 5g β-glucoside) Sorbitol
6.0gL-sodium ascorbate 20.0g alum
Dissolve 5.5 g of the mixture in 500-1000 ml of water or seawater and soak the seafood for 5-10 minutes to suppress browning of the seafood.
【図1】第1図は、本発明のチロシナーゼ阻害剤のチロ
シナーゼ阻害効果を表すグラフである。FIG. 1 is a graph showing the tyrosinase inhibitory effect of the tyrosinase inhibitor of the present invention.
Claims (4)
を表し、R2 は水素原子又は基 【化2】 を表し、但しR1 の少なくとも1つは必ず水素原子を
表すが、R1 のすべてとR2 が同時に水素を表すこ
とはない]を有する化合物を活性成分とするチロシナー
ゼ阻害剤。Claim 1: The following general formula I [Formula 1] [wherein R1 individually represents a hydrogen atom or a glucose residue, R2 represents a hydrogen atom or a group [Formula 2], provided that at least one of R1 is A tyrosinase inhibitor containing as an active ingredient a compound which always represents a hydrogen atom, but all of R1 and R2 do not represent hydrogen at the same time.
阻害剤。2. The tyrosinase inhibitor according to claim 1, which contains a compound of the formula [Image Omitted] as an active ingredient.
阻害剤。3. The tyrosinase inhibitor according to claim 1, which contains a compound of the formula [Image Omitted] as an active ingredient.
阻害剤。4. The tyrosinase inhibitor according to claim 1, which comprises a compound of the formula [Image Omitted] as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3002020A JPH04235112A (en) | 1991-01-11 | 1991-01-11 | Tyrosinase-inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3002020A JPH04235112A (en) | 1991-01-11 | 1991-01-11 | Tyrosinase-inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04235112A true JPH04235112A (en) | 1992-08-24 |
Family
ID=11517654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3002020A Pending JPH04235112A (en) | 1991-01-11 | 1991-01-11 | Tyrosinase-inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04235112A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011662A1 (en) * | 1993-10-26 | 1995-05-04 | Unilever Plc | Cosmetic composition comprising a hydrocalchone and optionally retinol or a derivative thereof |
EP0711541A1 (en) * | 1994-11-11 | 1996-05-15 | Harry H. Leveen | Use of glucose blockers for inhibiting hair growth |
FR2772613A1 (en) * | 1997-12-19 | 1999-06-25 | Oreal | Cosmetic compositions for stimulating keratinocyte proliferation, especially for skin treatment |
WO2002034222A1 (en) * | 2000-10-27 | 2002-05-02 | L'oreal | Use of 1,3-diphenylpropane derivatives as active principles in cosmetic compositions for inhibiting body odours |
JP2002193990A (en) * | 2000-12-25 | 2002-07-10 | Mitsui Chemicals Inc | Hydrochalcone glycoside and cosmetic formulated with the same as effective component |
CN103936606A (en) * | 2014-04-03 | 2014-07-23 | 陕西师范大学 | Water-soluble phloretin derivative and preparation method thereof |
EP2241303A3 (en) * | 2009-04-02 | 2015-09-02 | Sesvalia USA, LLC | Systems and methods for skin rejuvenation |
JP2021011455A (en) * | 2019-07-08 | 2021-02-04 | 株式会社林原 | PHLORETIN-4-α-GLUCOSIDE CRYSTAL |
-
1991
- 1991-01-11 JP JP3002020A patent/JPH04235112A/en active Pending
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995011662A1 (en) * | 1993-10-26 | 1995-05-04 | Unilever Plc | Cosmetic composition comprising a hydrocalchone and optionally retinol or a derivative thereof |
EP0711541A1 (en) * | 1994-11-11 | 1996-05-15 | Harry H. Leveen | Use of glucose blockers for inhibiting hair growth |
FR2772613A1 (en) * | 1997-12-19 | 1999-06-25 | Oreal | Cosmetic compositions for stimulating keratinocyte proliferation, especially for skin treatment |
EP0931542A1 (en) * | 1997-12-19 | 1999-07-28 | L'oreal | Cosmetic composition containing phloroglucinol |
JPH11246328A (en) * | 1997-12-19 | 1999-09-14 | L'oreal Sa | Use of phloroglucinol in cosmetic |
US6054137A (en) * | 1997-12-19 | 2000-04-25 | Societe L'oreal S.A. | Promoting epidermal renewal with phloroglucinol |
WO2002034222A1 (en) * | 2000-10-27 | 2002-05-02 | L'oreal | Use of 1,3-diphenylpropane derivatives as active principles in cosmetic compositions for inhibiting body odours |
FR2815856A1 (en) * | 2000-10-27 | 2002-05-03 | Oreal | USE OF 1,3-DIPHENYLPROPANE DERIVATIVES AS ACTIVE INGREDIENTS INHIBITING THE DEVELOPMENT OF BODY ODORS IN COSMETIC COMPOSITIONS |
JP2002193990A (en) * | 2000-12-25 | 2002-07-10 | Mitsui Chemicals Inc | Hydrochalcone glycoside and cosmetic formulated with the same as effective component |
EP2241303A3 (en) * | 2009-04-02 | 2015-09-02 | Sesvalia USA, LLC | Systems and methods for skin rejuvenation |
CN103936606A (en) * | 2014-04-03 | 2014-07-23 | 陕西师范大学 | Water-soluble phloretin derivative and preparation method thereof |
JP2021011455A (en) * | 2019-07-08 | 2021-02-04 | 株式会社林原 | PHLORETIN-4-α-GLUCOSIDE CRYSTAL |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3638832B2 (en) | Cosmetic and / or dermatological composition comprising at least one mulberry extract, at least one seaweed extract and at least one salicylic acid derivative | |
CN102838460B (en) | Skin whitening (blast) series of compounds | |
JPH0249715A (en) | Beautifying agent | |
EP0308278A1 (en) | Cosmetical use of N-acetylated or N-propionylated derivatives of proline, hydroxyproline and/or of the amino acids mixture resulting from the hydrolysis of collagen | |
JPH04235112A (en) | Tyrosinase-inhibitor | |
JP2903240B2 (en) | External preparation for skin | |
JPH03101609A (en) | External medicine for skin | |
JP2004517857A (en) | Whitening agent containing arbutin and glucosidase as active ingredients | |
KR100234563B1 (en) | Novel derivative of kojic acid and its use as a depigmenting agent | |
JP3460100B2 (en) | Whitening agent | |
JPS5811922B2 (en) | Keshiyouriyo | |
JPH09249544A (en) | Beautifully whitening agent | |
JP4239126B2 (en) | Tyrosinase activity inhibitor | |
JPH0925212A (en) | Skin preparation for external use | |
JPH0925214A (en) | Skin preparation for external use | |
JPH04235110A (en) | Tyrosinase-inhibitor | |
JPH09241154A (en) | Preparation for external use for skin | |
JPS5948808B2 (en) | cosmetics | |
JP2007022960A (en) | Melanogenesis inhibitor and bleaching cosmetic | |
JPH0820544A (en) | Reactive oxygen eliminator and food products and cosmetics formulated therewith | |
JP2006160701A (en) | Tyrosinase activity inhibitor and external preparation for skin | |
JP2006265141A (en) | Skin-whitening agent | |
JPH04352708A (en) | Cosmetic | |
JPH08301758A (en) | Skin preparation for external use | |
JPH0812552A (en) | Skin external preparation |